News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
250,401 Results
Type
Article (20691)
Company Profile (105)
Press Release (229605)
Multimedia
Podcasts (29)
Webinars (10)
Section
Business (78389)
Career Advice (825)
Deals (12426)
Drug Delivery (73)
Drug Development (24917)
Employer Resources (140)
FDA (4793)
Job Trends (6417)
News (121935)
Policy (9933)
Tag
Academia (1533)
Academic (2)
Accelerated approval (1)
Adcomms (16)
Allergies (22)
Alliances (23003)
ALS (32)
Alzheimer's disease (613)
Antibody-drug conjugate (ADC) (75)
Approvals (4824)
Artificial intelligence (137)
Autoimmune disease (10)
Automation (9)
Bankruptcy (57)
Best Places to Work (5149)
BIOSECURE Act (12)
Biosimilars (65)
Biotechnology (68)
Bladder cancer (37)
Brain cancer (8)
Breast cancer (107)
Cancer (834)
Cardiovascular disease (68)
Career advice (731)
Career pathing (31)
CAR-T (57)
Cell therapy (168)
Cervical cancer (8)
Clinical research (19692)
Collaboration (455)
Compensation (99)
Complete response letters (9)
COVID-19 (1067)
CRISPR (23)
C-suite (151)
Cystic fibrosis (41)
Data (824)
Decentralized trials (1)
Denatured (21)
Depression (16)
Diabetes (81)
Diagnostics (2731)
Digital health (6)
Diversity (7)
Diversity, equity & inclusion (37)
Drug discovery (60)
Drug pricing (44)
Drug shortages (4)
Duchenne muscular dystrophy (49)
Earnings (20858)
Editorial (16)
Employer branding (23)
Employer resources (118)
Events (34866)
Executive appointments (437)
FDA (5287)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (1)
Frontotemporal dementia (3)
Funding (401)
Gene editing (47)
Generative AI (14)
Gene therapy (119)
GLP-1 (323)
Government (1473)
Grass and pollen (1)
Guidances (53)
Healthcare (5693)
Huntington's disease (14)
IgA nephropathy (13)
Immunology and inflammation (28)
Indications (8)
Infectious disease (1130)
Inflammatory bowel disease (68)
Inflation Reduction Act (7)
Influenza (21)
Intellectual property (42)
Interviews (116)
IPO (4821)
IRA (16)
Job creations (1482)
Job search strategy (639)
Kidney cancer (1)
Labor market (39)
Layoffs (168)
Leadership (11)
Legal (2018)
Liver cancer (39)
Lung cancer (124)
Lymphoma (66)
Machine learning (2)
Management (42)
Manufacturing (154)
MASH (18)
Medical device (3481)
Medtech (3485)
Mergers & acquisitions (7908)
Metabolic disorders (236)
Multiple sclerosis (43)
NASH (10)
Neurodegenerative disease (32)
Neuropsychiatric disorders (5)
Neuroscience (836)
NextGen: Class of 2025 (2207)
Non-profit (1703)
Now hiring (39)
Obesity (138)
Opinion (97)
Ovarian cancer (32)
Pain (37)
Pancreatic cancer (22)
Parkinson's disease (56)
Partnered (13)
Patents (71)
Patient recruitment (31)
Peanut (13)
People (29704)
Pharmaceutical (26)
Pharmacy benefit managers (2)
Phase I (5657)
Phase II (8201)
Phase III (7662)
Pipeline (453)
Policy (54)
Postmarket research (756)
Preclinical (2899)
Press Release (62)
Prostate cancer (35)
Psychedelics (18)
Radiopharmaceuticals (74)
Rare diseases (145)
Real estate (2917)
Recruiting (54)
Regulatory (7188)
Reports (38)
Research institute (1312)
Resumes & cover letters (106)
Rett syndrome (1)
RNA editing (2)
RSV (26)
Schizophrenia (31)
Series A (81)
Series B (49)
Service/supplier (8)
Sickle cell disease (23)
Special edition (8)
Spinal muscular atrophy (54)
Sponsored (13)
Startups (2193)
State (1)
Stomach cancer (7)
Supply chain (28)
Tariffs (10)
The Weekly (8)
Vaccines (219)
Venture capitalists (31)
Weight loss (90)
Women's health (14)
Worklife (16)
Date
Last 7 days (328)
Last 30 days (1146)
Last 365 days (12065)
2025 (4418)
2024 (13629)
2023 (15602)
2022 (20539)
2021 (22100)
2020 (20371)
2019 (17521)
2018 (12870)
2017 (12833)
2016 (12426)
2015 (13865)
2014 (10339)
2013 (8911)
2012 (9433)
2011 (9729)
2010 (9036)
Location
Africa (383)
Alabama (22)
Alaska (4)
Arizona (75)
Arkansas (4)
Asia (28361)
Australia (3819)
California (2137)
Canada (781)
China (275)
Colorado (95)
Connecticut (76)
Delaware (88)
Europe (36974)
Florida (292)
Georgia (61)
Hawaii (1)
Idaho (11)
Illinois (145)
India (20)
Indiana (152)
Iowa (6)
Japan (132)
Kansas (32)
Kentucky (7)
Louisiana (5)
Maine (9)
Maryland (264)
Massachusetts (1677)
Michigan (97)
Minnesota (129)
Mississippi (1)
Missouri (33)
Montana (4)
Nebraska (9)
Nevada (13)
New Hampshire (14)
New Jersey (717)
New Mexico (16)
New York (761)
North Carolina (389)
North Dakota (8)
Northern California (979)
Ohio (70)
Oklahoma (6)
Oregon (17)
Pennsylvania (345)
Puerto Rico (3)
Rhode Island (8)
South America (464)
South Carolina (5)
Southern California (754)
Tennessee (32)
Texas (258)
United States (8170)
Utah (59)
Virginia (73)
Washington D.C. (25)
Washington State (162)
Wisconsin (42)
250,401 Results for "axovant sciences ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Lobe Sciences Ltd. Announces Private Placement to Support Drug Development of Novel Conjugated Psilocin(TM)
April 14, 2025
·
8 min read
Press Releases
Medicus Pharma Ltd. Announces a Binding Letter of Intent to Acquire Antev Ltd. for ~US$75 Million in a Share Exchange Transaction
Antev Shareholders to Receive Aggregate ~19% Equity Stake in Medicus, Plus US$65 Million in Contingent Payments
April 28, 2025
·
10 min read
Press Releases
AI/ML Innovations to Acquire Quantum Sciences Ltd
December 10, 2024
·
4 min read
Press Releases
AI/ML Innovations Closes Acquisition of Quantum Sciences Ltd.
December 24, 2024
·
8 min read
Press Releases
Kairos Pharma Ltd. Provides Letter to Stockholders
April 24, 2025
·
5 min read
Press Releases
Tenpoint Therapeutics Ltd. to Participate at Citi Biotech Private Access Day
April 23, 2025
·
1 min read
Press Releases
Tenpoint Therapeutics Ltd. to Participate in Upcoming Investor Conferences in April
April 1, 2025
·
2 min read
Press Releases
Hanx Biopharmaceuticals, Ltd. Showcases Five Innovative Cancer Therapies at 2025 AACR Annual Meeting
May 7, 2025
·
2 min read
Press Releases
Results from the VirTus Respiratory Research Ltd Human Rhinovirus Challenge Model Used to Advance Altesa BioSciences’ Lead Medicine into Advanced Clinical Trials
May 8, 2025
·
5 min read
Lobe Sciences Ltd. and Clearway Global Announce Change of Control and Focus on Creating Value for Shareholders
Lobe Sciences Ltd., a biopharmaceutical company focused on developing transformative medicines to treat rare diseases and Clearway Global, LLC, a wholly owned subsidiary of Sancilio & Company, a pharmaceutical services company focused on value creation strategies, are pleased to announce a change in control of the Company and several enhancements to its ongoing growth strategy.
May 21, 2024
·
5 min read
1 of 25,041
Next
